{"id":"W2225863772","doi":"10.1200/jco.2007.25.18_suppl.550","title":"A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Hazard ratio; Paclitaxel; Gastroenterology; Proportional hazards model; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004766635,0.0007583135,0.00565501,0.000575915,0.0001418615,0.00002312467,0.0005342914,0.0006870324,0.0009236161],"category_scores_gemma":[0.001741993,0.000534214,0.0006179344,0.00124915,0.0006728689,0.0002442643,0.0001367006,0.001805841,0.00002044933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002992228,"about_ca_system_score_gemma":0.004327425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00433128,"about_ca_topic_score_gemma":0.00406796,"domain_scores_codex":[0.9899444,0.001422122,0.005272675,0.0009253591,0.001086745,0.001348713],"domain_scores_gemma":[0.985886,0.006417894,0.003946761,0.0004556101,0.001263586,0.002030186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8772106,0.01589192,0.01141671,0.00005096986,0.002620029,0.002297784,0.003447528,0.0002233812,0.02964349,0.000004606912,0.04074093,0.01645204],"study_design_scores_gemma":[0.7612998,0.1500035,0.06457952,0.001130054,0.002891585,0.0004383127,0.00344558,0.0002076165,0.008207018,0.00009032029,0.006698458,0.001008197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810919,0.0002354165,0.0009527688,0.01053095,0.001823929,0.003099795,0.001868703,0.00003599772,0.0003606038],"genre_scores_gemma":[0.9872481,0.000336922,0.004735176,0.005796981,0.0008963345,0.000271492,0.00007674778,0.00007846756,0.0005597306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1341116,"threshold_uncertainty_score":0.9999897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06350505833528398,"score_gpt":0.4623515918723846,"score_spread":0.3988465335371006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}